Effect of human hemoglobin on systemic and regional hemodynamics in a porcine model of endotoxemic shock

Critical Care Medicine

Volumn 24, Issue 5, 1996, Pages 807-814

  Aranow, Jonathan S ^a   Wang, Hailong ^a   Zhuang, Jing ^a   Fink, Mitchell P ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

adult respiratory distress syndrome; blood substitutes; critical illness; endothelium derived relaxing factor; endotoxin; hemoglobin; infection; lipopolysaccharide; nitric oxide; sepsis; septic shock

Indexed keywords

DEXTRAN 70; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HEMOGLOBIN; RINGER LACTATE SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; ENDOTOXEMIA; HEART INDEX; HEMODYNAMICS; HYPOTENSION; INFUSION; INTESTINE BLOOD FLOW; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; LUNG ARTERY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SWINE; SYSTEMIC VASCULAR RESISTANCE;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HEMODYNAMIC PROCESSES; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NITRIC OXIDE; PROSPECTIVE STUDIES; RANDOM ALLOCATION; SHOCK, SEPTIC; SWINE;

EID: 0030007689     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199605000-00014     Document Type: Article

References (58)

1. Abraham E, Shoemaker WC, Bland RD, et al: Sequential cardiorespiratory patterns in septic shock. Crit Care Med 1983; 11:799-803
2. Ruokonen E, Takala J, Kari A, et al: Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993; 21:1296-1303
3. Szabó C: Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 1995; 3:2-32
4. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
5. Ignarro LJ, Byrns RE, Buga GM, et al: Endothelium-dependent relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61:866-879
6. Geng Y-j, Hansson GK, Holme E: Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 1992; 71:1268-1276
7. Schneider F, Bucher B, Schott C, et al: Effect of bacterial lipopolysaccharide on function of rat small femoral arteries. Am J Physiol 1994; 266:H191-H198
8. Koide M, Kawahara Y, Tsuda T, et al: Expression of nitric oxide synthase by cytokines in vascular smooth muscle cells. Hypertension 1994; 23:145-148
9. Koide M, Kawahara Y, Nakayama I, et al: Cyclic AMP-elevating agents induce an inducable type of nitric oxide synthase in culture vascular smooth muscle cells. Synergism with the induction of inflammatory cytokines. J Biol Chem 1993; 268:24959-24966
10. Evans T, Carpenter A, Kinderman H, et al: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41:77-81
11. Ochoa JB, Udekwu AO, Billiar TR, et al: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214:621-626
12. Jimenez-Gomez J, Salgado A, Mourelle M, et al: L-arginine:nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23:253-258
13. Lorente JA, Landin L, Renes E, et al: Role of nitric oxide in the hemodynamic changes of sepsis. Crit Care Med 1993; 21:759-767
14. Thiemermann C, Vane J: Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 1990; 182:591-595
15. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172:1132-1138
16. Pastor C, Teisseire B, Vicaut E, et al: Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med 1994; 22: 465-169
17. Roberston FM, Offner PJ, Ciceri DP, et al: Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994; 129:149-156
18. Lorente JA, Landin L, de Pablo R, et al: L-arginine pathway in the sepsis syndrome. Crit Care Med 1993; 21: 1287-1295
19. Petros A, Bennett D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-1558
20. Petros A, Lamb G, Leone A, et al: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28:34-39
21. Meyer J, Lentz CW, Stothert JC Jr, et al: Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med 1994; 22:306-312
22. Meyer J, Traber LD, Nelson S, et al: Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 1992-73:324-328
23. Martin CM, Sibbald WJ: Modulation of hemodynamics and organ blood flow by nitric oxide synthase inhibition is not altered in normotensive, septic rats. Am J Respir Crit Care Med 1994; 150: 1539-1544
24. Teale DM, Atkinson AM: Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 1992; 30:839-842
25. Evans T, Carpenter A, Silva A, et al: Inhibition of nitric oxide synthase in experimental Gram-negative sepsis. J Infect Dis 1994; 169:343-349
26. Szabó C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducable nitric oxide synthase. Proc Natl Acad Sci USA 1994; 91:12472-12476
27. Wu CC, Chen SJ, Szabo C, et al: Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 1995; 114:1666-1672
28. Spain DA, Wilson MA, Garrison RN: Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 1994; 116:322-331
29. Mulder MF, van Lambalgen AA, Huisman E, et al: Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am J Physiol 1994; 266:H1558-H1564
30. Minnard EA, Shou J, Naama H, et al: Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 1994; 129:142-148
31. ωamino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992; 176:1175-1182
32. G-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukocyte Biol 1990; 48: 565-569
33. Harbrecht BG, Stadler J, Demetris AJ, et al: Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol 1994; 266:G1004-G1010
34. Sharma VS, Traylor TG, Gardiner R, et al: Reaction of nitric oxide with heme proteins and model compounds of hemoglobin. Biochemistry 1987; 26: 3837-3843
35. Wang QZ, Jacobs J, DeLeo J, et al: Nitric oxide hemoglobin in mice and rats in endotoxic shock. Life Sci 1991; 49: PL55-PL60
36. Goretski J, Hollocher TC: Trapping of nitric oxide produced during denitrification by extracellular hemoglobin. J Biol Chem 1988; 263:2316-2323
37. Iwamoto J, Morin FC: Nitric oxide inhibition varies with hemoglobin saturation. J Appl Physiol 1993; 75:2332-2336
38. Martin W, Smith JA, White DG: The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Br J Pharmacol 1986; 89:563-571
39. Sharma AC, Gulati A: Effect of diaspirin cross-linked hemoglobin and norepinephrine on systemic hemodynamics and regional circulation in rats. J Lab Clin Med 1994; 123:299-308
40. Schultz SC, Grady B, Cole F, et al: A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993; 122:301-308
41. Crowley JP, Metzger J, Gray A, et al: Infusion of stroma-free cross-linked hemoglobin during acute Gram-negative bacteremia. Circ Shock 1993; 41:144-149
42. Antonsson JB, Boyle CC, Kruithoff KL, et al: Validation of tonometric measurement of gut intramural pH during endotoxemia and mesenteric occlusion in pigs. Am J Physiol 1990; 259:G519-G523
43. Nava E, Palmer RMJ, Moncada S: Inhibition of nitric oxide synthesis in septic shock: How much is beneficial. Lancet 1991; 338:1555-1557
44. Zapol WM, Snider MT: Pulmonary hypertension in severe acute respiratory failure. N Engl J Med 1977; 296:476-480
45. Asano K, Chee CBE, Gaston B, et al: Constituitive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 1994; 91:10089-10093
46. Shaul PW, North AJ, Wu LC, et al: Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J Clin Invest 1994; 94: 2231-2236
47. McQuillan LP, Leung GK, Marsden PA, et al: Hypoxia inhibitis expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol 1994; 267:H1921-H1927
48. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88:4651-4654
49. Radomski MW, Palmer RMJ, Moncada S: The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987; 148:1482-1489
50. Sneddon JM, Vane JR: Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci U S A 1988; 85:2800-2804
51. Radomski MW, Vallance P, Whitley G, et al: Platelet adhesion to human vascular endothelium is modulated by constituitive and cytokine induced nitric oxide synthase. Cardiovasc Res 1993; 27:1380-1382
52. Naureckas ET, Factor P, Benjaminov O, et al: Pentoxyfylline does not protect against hyperoxic lung injury in rats. Eur Respir J 1994; 7:1397-1402
53. Kennedy TP, Rao NV, Noah W, et al: Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron. J Clin Invest 1990; 86: 1565-1573
54. Hedlund BE, Hallaway PE: Role of iron and oxygen radicals in hemorrhage and shock. Klin Wochenschr 1991; 69: 1113-1117
55. Kaka W, Roth RI, Levin J: Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LSP biological activity. J Biol Chem 1994; 40:25078-25084
56. McFaul SJ, Bowman PD, Villa VM, et al: Hemoglobin stimulates mononuclear cells to release interleukin-8 and tumor necrosis factor a. Blood 1994; 84:3175-3181
57. Warner AE, Brain JD: The cell biology and pathogenic role of pulmonary intravascular macrophages. Am J Physiol 1990; 258:L1-L12
58. Molton D, Bertram TA: Isolation and preliminary in vitro characterization of the porcine pulmonary intravascular macrophage. J Leukocyte Biol 1988; 43:403-410